T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding T2 Biosystems, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 79 | 76 | −3 |
| Shares | 19.2M | 15.3M | −3.95M (−20.5%) |
| Value | $9.92M | $7.97M | −$1.94M (−19.6%) |
New holders (4)
Institutions that held T2 Biosystems, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 20,000 | $10.0K | 0.00% |
| WealthPlan Investment Management, LLC | 25,300 | $9.00K | 0.00% |
| FMR LLC | 16 | $0 | 0.00% |
| First Manhattan Co | 502 | $0 | 0.00% |
Sold out (7)
Institutions that held T2 Biosystems, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Two Sigma Securities, LLC | 55,782 | $29.0K |
| Charles Schwab Investment Management Inc | 47,515 | $25.0K |
| Atom Investors LP | 23,023 | $12.0K |
| JPMorgan Chase & Co | 17,566 | $9.00K |
| Gilman Hill Asset Management, LLC | 11,000 | $6.00K |
| Washington Trust Co | 2,400 | $1.00K |
| Amplius Wealth Advisors, LLC | 500 | $0 |